- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Prenetics Global Limited: World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder | 2 | GlobeNewswire (USA) | ||
| Mo | Prenetics stock steady as Cantor reiterates rating on divestiture news | 1 | Investing.com | ||
| Mo | Prenetics-Aktie stabil: Cantor bekräftigt Bewertung nach Veräußerungsnachricht | 1 | Investing.com Deutsch | ||
| 20.06. | Bitcoin im Gesundheitssektor: Prenetics wagt mutigen Schritt in neue Märkte | 4 | Coin-Update.de | ||
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 18.06. | Bitcoin-Wette: Gesundheitsunternehmen Prenetics investiert $20M, nachdem die Marktkapitalisierung um 94% gesunken ist | 3 | Bitcoin.com News | ||
| 18.06. | Prenetics becomes first healthcare firm to acquire bitcoin for treasury | 1 | Investing.com | ||
| 18.06. | Prenetics Acquires $20 Million In Bitcoin To Boost Healthcare Bitcoin Treasury Strategy | 1 | Benzinga.com | ||
| 18.06. | Prenetics Global Limited: Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board | 2 | GlobeNewswire (USA) | ||
| 18.06. | Prenetics Global divests ACT Genomics for $46M | 1 | Seeking Alpha | ||
| 18.06. | Prenetics to sell ACT Genomics stake to Delta Electronics for $46 million | 1 | Investing.com | ||
| 18.06. | Prenetics Global Limited: Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction | 1 | GlobeNewswire (USA) | ||
| 16.06. | Cantor Fitzgerald raises Prenetics price target on strong quarterly results | 1 | Investing.com | ||
| 13.06. | Prenetics stock price target raised to $14 from $13 at Cantor Fitzgerald | 1 | Investing.com | ||
| 12.06. | Kursziel für Prenetics-Aktie nach starken Q1-Ergebnissen auf 14 US-Dollar angehoben | 1 | Investing.com Deutsch | ||
| 12.06. | Prenetics stock price target raised to $14 on strong Q1 results | 1 | Investing.com | ||
| 12.06. | Prenetics Global veröffentlicht Finanzergebnisse für Q1 2025 | 1 | Investing.com Deutsch | ||
| 12.06. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.05. | Prenetics Global Ltd - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 30.04. | Prenetics Global Ltd - 20-F, Annual and transition report of foreign private issuers | 3 | SEC Filings |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CANSINO BIOLOGICS | 3,680 | -0,54 % | CanSino Biologics Inc: CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health | HONG KONG, June 20, 2025 - (ACN Newswire) - Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single... ► Artikel lesen | |
| SINO BIOPHARM | 0,580 | +1,54 % | SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - NEW INDICATION OF LM-108 ("CCR8 MONOCLONAL ANTIBODY") INCLUDED IN BREAKTHROUGH THERAPY DESIGNATION PROCESS | ||
| GENSCRIPT BIOTECH | 1,634 | +3,19 % | GenScript Biotech Corporation Reports FY 2024 Results | Strategic deconsolidation of Legend Biotech unlocked significant value, while core businesses experienced rapid growth.
PISCATAWAY, N.J., March 12, 2025 /PRNewswire/... ► Artikel lesen | |
| QUANTUM-SI | 1,935 | -5,61 % | Quantum-Si Incorporated: Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK | Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company, announces its participation in the upcoming Festival of Genomics UK, taking place on... ► Artikel lesen | |
| INNOVENT BIOLOGICS | 8,300 | -1,19 % | Innovent Biologics' Mazdutide Gets China Approval For Chronic Weight Management | BEIJING (dpa-AFX) - Innovent Biologics, Inc. (IVBXF.OB) announced Friday that China's National Medical Products Administration or NMPA has approved mazdutide for chronic weight management in... ► Artikel lesen | |
| SCILEX | 6,030 | +14,20 % | Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May ... | ||
| ORIGIN AGRITECH | 0,880 | -2,22 % | Origin Agritech Limited: Origin Agritech Announced Financial Results for the Six Months Ended March 31, 2025 | BEIJING, June 26, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today... ► Artikel lesen | |
| AKESO | 9,850 | -2,48 % | Akeso, Inc.: Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025 | HONG KONG, June 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") presented the subgroup analysis data from the Phase III COMPASSION-16... ► Artikel lesen | |
| SOLID BIOSCIENCES | 4,720 | -1,87 % | Citi startet Berichterstattung für Solid Biosciences mit Kaufempfehlung | ||
| HARMONY BIOSCIENCES | 31,980 | +0,38 % | Mizuho reaffirms Harmony Biosciences stock rating on positive orexin data | ||
| CG ONCOLOGY | 25,950 | -0,46 % | CG Oncology Inc.: CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates | - Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete response rate of 42.3% by K-M -- Promising early signal... ► Artikel lesen | |
| QIAGEN | 41,000 | -0,56 % | Minimale Kursveränderung bei Qiagen NV-Aktie (40,55 €) | Am Aktienmarkt ist der Anteilsschein von Qiagen NV gegenwärtig unauffällig. Das Wertpapier kostete zuletzt 40,55 Euro. Der heutige Börsentag brachte bislang wenig Kursbewegung bei der Aktie von Qiagen... ► Artikel lesen | |
| LYELL IMMUNOPHARMA | 8,940 | -1,97 % | Lyell Immunopharma, Inc. - 8-K, Current Report | ||
| SPRINGWORKS THERAPEUTICS | 46,990 | 0,00 % | SpringWorks Therapeutics, Inc. - 8-K, Current Report | ||
| KYMERA THERAPEUTICS | 44,080 | -3,57 % | Gilead Sciences Partners Kymera Therapeutics To Develop Novel Oral Molecular Glue CDK2 Degraders | FOSTER CITY (dpa-AFX) - Gilead Sciences, Inc. (GILD) and Kymera Therapeutics, Inc. (KYMR) announced Wednesday that they have entered into an exclusive option and license agreement to accelerate... ► Artikel lesen |
Das Unternehmen PRENETICS GLOBAL LIMITED kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,560 (-6,22 %) liegt der Kurs bei 8,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.